首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

EMBO Molecular Medicine
ISSN：1757-4676

EMBO Molecular Medicine

恩博分子医学
EMBO MOL MED
学科领域：医学
是否预警：不在预警名单内
是否OA：是
录用周期：偏慢,4-8周
新锐分区：医学1区
年发文量：159
影响因子：8.3
JCR分区：Q1

基本信息

恩博分子医学《EMBO分子医学》是一本开放获取的期刊，致力于临床研究和生命科学之间的接口科学。《EMBO分子医学》具有公平和透明的流程（http：//embomolmed.embopress.org/about#Transparent_Process），可快速发表重要的科学成果。匿名评审报告和编辑通信与手稿一起作为审查过程文件在透明过程部分在线发布。
1757-4676SCIE/Scopus收录/DOAJ开放期刊
8.3
点击查看最新影响趋势>
7.5
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学1区
MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验
1区
是
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：MEDICINE, RESEARCH & EXPERIMENTAL
SCIE
Q1
21/195
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：MEDICINE, RESEARCH & EXPERIMENTAL
SCIE
Q1
13/195
90
159
点击查看年发文量趋势图>
5%较难偏慢,4-8周EUR6490; GBP5590; USD6890医学-医学：研究与实验
0%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
93.08%96.24%3.09%
CiteScore：15.90
SJR：3.571
SNIP：1.724
学科类别分区排名百分位
大类：Biochemistry, Genetics and Molecular Biology
小类：Molecular Medicine
Q1
15 / 177

期刊高被引文献

Inflammasomes in neuroinflammatory and neurodegenerative diseases
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201810248
The role of the microbiome in NAFLD and NASH
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809302
A dual‐AAV approach restores fast exocytosis and partially rescues auditory function in deaf otoferlin knock‐out mice
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809396
Cellular, molecular, and clinical mechanisms of action of deep brain stimulation—a systematic review on established indications and outlook on future developments
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809575
Cerebral malaria is associated with differential cytoadherence to brain endothelial cells
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809164
Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809958
Progerin accelerates atherosclerosis by inducing endoplasmic reticulum stress in vascular smooth muscle cells
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809736
ADAM17 selectively activates the IL‐6 trans‐signaling/ERK MAPK axis in KRAS‐addicted lung cancer
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809976
A circRNA signature predicts postoperative recurrence in stage II/III colon cancer
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201810168
Inhibition of proteasome rescues a pathogenic variant of respiratory chain assembly factor COA7
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809561
Lipid droplet‐dependent fatty acid metabolism controls the immune suppressive phenotype of tumor‐associated macrophages
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910698
The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancer
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910659
Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809034
Dyslipidemia in retinal metabolic disorders
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910473
Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910547
Epigenetic silencing of SALL2 confers tamoxifen resistance in breast cancer
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910638
Plasma Proteome Profiling to detect and avoid sample‐related biases in biomarker studies
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910427
3,4‐Dimethoxychalcone induces autophagy through activation of the transcription factors TFE3 and TFEB
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910469
Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910924
Control of anterior GRadient 2 (AGR2) dimerization links endoplasmic reticulum proteostasis to inflammation
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201810120
Activation of LXRβ inhibits tumor respiration and is synthetically lethal with Bcl‐xL inhibition
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910769
Requirement for YAP1 signaling in myxoid liposarcoma
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809889
Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809539
Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK‐rearranged lung cancer
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910581
Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809982
CoA‐dependent activation of mitochondrial acyl carrier protein links four neurodegenerative diseases
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910488
Efficacy of simultaneous VEGF‐A/ANG‐2 neutralization in suppressing spontaneous choroidal neovascularization
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201810204
Repurposing the yellow fever vaccine for intratumoral immunotherapy
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910375
Non‐canonical cMet regulation by vimentin mediates Plk1 inhibitor–induced apoptosis
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809960
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910666
Dynorphin‐based “release on demand” gene therapy for drug‐resistant temporal lobe epilepsy
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809963
APOPT1/COA8 assists COX assembly and is oppositely regulated by UPS and ROS
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809582
DNA methylation inhibitor attenuates polyglutamine‐induced neurodegeneration by regulating Hes5
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201708547
Malaria inflammation by xanthine oxidase‐produced reactive oxygen species
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809903
Gender and sex—time to bridge the gap
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910668
The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910849
Toward personalized TGFβ inhibition for pancreatic cancer
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201911414
Genetically engineered distal airway stem cell transplantation protects mice from pulmonary infection
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201810233
Stop wasting protein—Proteasome inhibition to target diseases linked to mitochondrial import
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910441
Gut microbes, ageing & organ function: a chameleon in modern biology?
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809872
I BET on anti‐FGFR to fight cancer resistance
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201810116
Endoplasmic reticulum stress at the crossroads of progeria and atherosclerosis
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910360
An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809830
Funding community collaboration to develop effective therapies for neurofibromatosis type 1 tumors
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201911656
How much does a disrupted mitochondrial network influence neuronal dysfunction?
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201809899
What is normal? Apelin and VEGFA, drivers of tumor vessel abnormality
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910892
Inhibiting TRF1 upstream signaling pathways to target telomeres in cancer cells
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201910845
An allosteric inhibitor of Mycobacterium tuberculosis ArgJ: Implications to a novel combinatorial therapy
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201911209
In search of the next super models
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201911502
Live vaccines—a short‐cut to cancer viro‐immunotherapy
来源期刊：EMBO Molecular MedicineDOI：10.15252/emmm.201911496

相关文章

8.8分、国人占比仅2%：British Journal of Surgery，这本百年外科圣殿为何让中国外科医生望而却步？
2026-06-04
从6.7到4.9，年发文682篇：PLoS Pathogens，这本病原微生物界的“联合国”如何用开放获取重塑全球公共卫生研究
2026-06-04
影响因子2.9、国人占比23%：这本Q3免疫期刊如何为细胞免疫基础研究守住最后阵地？
2026-06-04
Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15

期刊推荐

Acta Biomaterialia封面

Acta Biomaterialia

学科领域：医学
影响因子：9.6
中科院分区： 1区
ACTA PHARMACOLOGICA SINICA封面

ACTA PHARMACOLOGICA SINICA

学科领域：医学
影响因子：8.4
中科院分区： 1区
ADVANCED DRUG DELIVERY REVIEWS封面

ADVANCED DRUG DELIVERY REVIEWS

学科领域：医学
影响因子：17.6
中科院分区： 1区
AGEING RESEARCH REVIEWS封面

AGEING RESEARCH REVIEWS

学科领域：医学
影响因子：12.4
中科院分区： 1区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学1区
MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验
1区
是
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学1区
MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验
1区
是
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学1区
MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验
1区
是
否